Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.

[1]  Y. Okada,et al.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. , 1999, The American journal of pathology.

[2]  M. Noguchi,et al.  Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. , 1999, Cancer research.

[3]  S. Ishida,et al.  The genomic breakpoint and chimeric transcripts in the EWSR1–ETV4/E1AF gene fusion in Ewing sarcoma , 1998, Cytogenetic and Genome Research.

[4]  H. Sato,et al.  Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells. , 1998, Biochemical and biophysical research communications.

[5]  M. Quintanilla,et al.  Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[6]  P. Brodt,et al.  Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. , 1998, Cancer research.

[7]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[8]  J. Hata,et al.  Molecular Analysis of Ewing's Sarcoma: Another Fusion Gene, EWS‐E1AF, Available for Diagnosis , 1998, Japanese journal of cancer research : Gann.

[9]  Y. Okada,et al.  Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. , 1998, Cancer research.

[10]  M. Klemsz,et al.  Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression , 1997, Molecular and cellular biology.

[11]  Marcienne M Wright,et al.  EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic , 1997, Nature Genetics.

[12]  Y. Okada,et al.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. , 1997, Cancer research.

[13]  A. Roessner,et al.  Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. , 1997, General & diagnostic pathology.

[14]  Y. Seyama,et al.  Anti‐α3 integrin antibody induces the activated form of matrix metalloprotease‐2 (MMP‐2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells , 1997, International journal of cancer.

[15]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[16]  D. Stéhelin,et al.  Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. , 1996, Oncogene.

[17]  Z. Gokaslan,et al.  Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin , 1996 .

[18]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[19]  Y. Okada,et al.  Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasis , 1995, International journal of cancer.

[20]  C. Denny,et al.  Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis , 1995, Molecular and cellular biology.

[21]  Y. Okada,et al.  Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. , 1995, Cancer research.

[22]  T. Noumi,et al.  Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.

[23]  C. Denny,et al.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. , 1995, Oncogene.

[24]  R. Pankov,et al.  AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells , 1994, Molecular and cellular biology.

[25]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[26]  S. Imai,et al.  Immortalization-susceptible elements and their binding factors mediate rejuvenation of regulation of the type I collagenase gene in simian virus 40 large T antigen-transformed immortal human fibroblasts , 1994, Molecular and cellular biology.

[27]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[28]  Renato Paro,et al.  Mapping polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin , 1993, Cell.

[29]  T. Triche,et al.  Combinatorial generation of variable fusion proteins in the Ewing family of tumours. , 1993, The EMBO journal.

[30]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[31]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[33]  Y. Kaneko,et al.  Evidence for heterogeneous groups of neuronal differentiation of Ewing's sarcoma. , 1991, British Journal of Cancer.

[34]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[35]  K. Tachibana,et al.  Colony-stimulating factor 1 expression is down-regulated during the adipocyte differentiation of H-1/A marrow stromal cells and induced by cachectin/tumor necrosis factor , 1991, Molecular and cellular biology.

[36]  D. Brenner,et al.  A simplified method for the preparation of transcriptionally active liver nuclear extracts. , 1990, DNA and cell biology.

[37]  Y. Kaneko,et al.  Establishment and Characterization of a Small Round Cell Sarcoma Cell Line, SCCH‐196, with t(11;22)(q24;q12) , 1989, Japanese journal of cancer research : Gann.

[38]  T. Hongo,et al.  Cell culture of small round cell tumor originating in the thoracopulmonary region. Evidence for derivation from a primitive pluripotent cell , 1989, Cancer.

[39]  M. Israel,et al.  Chromosome translocation in peripheral neuroepithelioma. , 1984, The New England journal of medicine.

[40]  D. Steiner,et al.  Expression of a preproinsulin-beta-galactosidase gene fusion in mammalian cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[42]  J. Ewing.  Diffuse endothelioma of bone , 1972 .

[43]  H. Sato,et al.  Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. , 1992, Oncogene.